DPH 50 MG Chewable Tablet [Dilantin]
- RxCUI
- 1313887
- RxNorm name
- DPH 50 MG Chewable Tablet [Dilantin]
- Display name
- DPH 50 MG Chewable Tablet [Dilantin]
- Full name
- DPH 50 MG Chewable Tablet [Dilantin]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dilantin Infatabs | PHENYTOIN | Parke-Davis Div of Pfizer Inc | ca119a89-2394-4d34-8078-cd1fa4e8e2f1 | 2026-05-12 | Warnings, Adverse reactions | 1313887 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ca119a89-2394-4d34-8078-cd1fa4e8e2f1 | Dilantin INFATABS 50 MG Chewable Tablet [PSN] · phenytoin 50 MG Chewable Tablet [Dilantin] [SBD] · Dilantin 50 MG Chewable Tablet [SY] · Dilantin Infatabs 50 MG Chewable Tablet [SY] · DPH 50 MG Chewable Tablet [Dilantin] [SY] | 5 | 58 | These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . INFATABS ® DILANTIN ® (phenytoin chewable tablets), for oral use Initial U.S. Approval: 1953 | 20260512 |